Skip to content

Nettle and Cranberry Capsules for Prevention of Urinary Tract Infection

Clinical Trial of Nettle and Cranberry Capsules for Prevention of Urinary Tract Infection

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05880602
Enrollment
60
Registered
2023-05-30
Start date
2023-07-05
Completion date
2023-12-31
Last updated
2025-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Tract Infection

Keywords

Nettle, Cranberry, Prevention, Urinary Tract Infection, Recurrent Infection, Inflammation

Brief summary

This study investigates whether the oral intake of a nettle and cranberry complex capsule may prevent recurrent urinary tract infection (rUTI). Participants will be aged between 30 - 75 years of age, with confirmed diagnosis of UTI status. The participants will be assessed for several parameters and asked to take 2 nettle and cranberry complex capsules twice daily for 8 weeks. The parameters will include international prostate symptoms score (IPSS), overactive bladder symptom score (OABSS), international consultation on incontinence questionnaire - overactive bladder (ICIQ-OAB), 3-day bladder diary (3dBD), and urine routine.

Detailed description

Urinary tract infections (UTIs) are one of the most common bacterial infections affecting women. UTI occurs in 50-80% of women in the general population. About one in four women with one UTI episode will go on to develop frequent recurrences. Recurrent urinary tract infection (rUTI) is defined as repeated UTI with a frequency of at least two episodes in the preceding six months or three episodes in the past year. rUTI has been regarded as a substantial global healthcare problem. This investigation is a randomized, double-blind study. Subjects with confirmed diagnosis of rUTI are randomly assigned to control group or treatment group, and asked to orally intake 2 capsules of either placebo or nettle and cranberry complex capsules twice daily. Participants will be assessed for parameters, including international prostate symptoms score (IPSS) (male only), overactive bladder symptom score (OABSS), international consultation on incontinence questionnaire - overactive bladder (ICIQ-OAB), 3-day bladder diary (3dBD) and urine routine. The assessments are conducted at baseline, 4 weeks, and 8 weeks after the oral intake period. The parameters are used to compare and evaluate whether the nettle and cranberry complex capsule can prevention rUTI.

Interventions

DIETARY_SUPPLEMENTNettle and Cranberry complex capsules

A specific capsule product, containing nettle and cranberry complex will be given to participants for oral intake for 8 weeks.

DIETARY_SUPPLEMENTPlacebo(starch)

A specific capsule product, containing starch will be given to participants for oral intake for 8 weeks.

Sponsors

Glory Kingdom Corporation
CollaboratorUNKNOWN
Chung Shan Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
30 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* aged between 30 and 75 years * at least two episodes in 6 months, or at least three episodes of a UTI in 12 months.

Exclusion criteria

* pregnancy women * diabetes * History of anatomical urogenital anomalies, urogenital tract surgery * History of acute or chronic renal failure, nephrolithiasis * History of intestinal diseases causing malabsorption * Anticoagulant medication in the last month * immunocompromise * Known allergy or intolerance to cranberry

Design outcomes

Primary

MeasureTime frameDescription
UTI-free duration in 8 weekson baseline and 8 weeksComparing the number of days from the beginning of the study to the first recurrence of UTI, and the number of days from each recurrence to the next recurrence between different treatment groups.
UTI recurrent incidence in 8 weeks8 weeksUTI episodes during 8 weeks treatment for each subject

Secondary

MeasureTime frameDescription
International Prostate Symptom Score (IPSS) Change from Baselineon baseline,4 weeks and 8 weeksThe IPSS questionnaire is a tool commonly used to assess the severity of LUTS, and to monitor the progress of the symptoms during treatment. Score range is 0-35, with higher scores indicating increasing symptom severity.
Overactive Bladder Symptom Score (OABSS) Change from Baselineon baseline,4 weeks and 8 weeksOABSS is a valid self-assessment questionnaire, with four questions set according to OAB syndrome to determine the severity of OAB, which includes daytime and nighttime urination frequency, urgency, and urge incontinence. Score range is 0-15, with higher scores indicating increasing symptom severity.
International Consultation on Incontinence Questionnaire Overactive Bladder Score (ICIQ-OAB) Change from Baselineon baseline,4 weeks, and 8 weeksAssessment of quality of life related to the impact of overactive bladder symptoms on daily activities. Assessment of quality of life related to the impact of overactive bladder symptoms on daily activities Assessment of quality of life related to the impact of overactive bladder symptoms on daily activities.
Bladder diaryon baseline,4 weeks, and 8 weeksAssessment of number of voids, number of leakages, and post void residual.

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026